# Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.

> **NCT06225882** · — · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 100 (estimated)

## Conditions studied

- Patients With PH1 Treated With Lumasiran in France

## Interventions

- **DRUG:** Oxaluria evolution.

## Key facts

- **NCT ID:** NCT06225882
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06225882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06225882, "Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06225882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*